A novel soluble β-1,3-d-glucan Salecan reduces adiposity and improves glucose tolerance in high-fat diet-fed mice

British Journal of Nutrition

Volumn 109, Issue 2, 2013, Pages 254-262

  Zhang, Ying ^a   Xia, Lin ^a   Pang, Wenqiang ^a   Wang, Tao ^a   Chen, Peng ^a   Zhu, Bin ^a   Zhang, Jianfa ^a  

^a NANJING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Glucans; Glucose tolerance; High fat diet; Obesity; Salecan

Indexed keywords

BETA 1,3 GLUCAN; BILE ACID; CELLULOSE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SALECAN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; FAT DROPLET;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; EMULSION; FAT MASS; FEMALE; GLUCOSE TOLERANCE; IN VITRO STUDY; LIPID DIET; LIPID STORAGE; LIVER WEIGHT; MOUSE; NONHUMAN; OBESITY; TRIACYLGLYCEROL BLOOD LEVEL; BODY FAT; DOSE RESPONSE; FAT CONTENT; FAT INTAKE; FECES; GLUCOSE BLOOD LEVEL; LIPID ABSORPTION; LIVER LEVEL;

ADIPOSITY; ANIMALS; ANTI-OBESITY AGENTS; BETA-GLUCANS; CELL SIZE; DIET, HIGH-FAT; DIETARY FATS; DIETARY SUPPLEMENTS; EMULSIFYING AGENTS; FECES; FEMALE; GLUCOSE INTOLERANCE; INTESTINAL ABSORPTION; INTRA-ABDOMINAL FAT; LIPID METABOLISM; LIVER; MICE; MICE, INBRED C57BL; OBESITY; ORGAN SIZE; SOLUBILITY; WEIGHT GAIN;

EID: 84873041429     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512000980     Document Type: Article

References (51)

1. Ogden CL, Carroll MD, Curtin LR, et al.(2006) Prevalence of overweight and obesity in the United States, 1999-2004 JAMA 295, 1549-1555
2. Spiegelman BM & Flier JS (2001) Obesity and the regulation of energy balance. Cell 104, 531-543
3. Metges CC (2009) Early nutrition and later obesity: Animal models provide insights into mechanisms. Adv Exp Med Biol 646, 105-112
4. Kahn BB & Flier JS (2000) Obesity and insulin resistance. J Clin Invest 106, 473-481
5. Stienstra R, Duval C, Muller M, et al.(2007) PPARs, Obesity, and Inflammation. PPAR Res 2007, 95974
6. Pischon T, Nothlings U & Boeing H (2008) Obesity and cancer. Proc Nutr Soc 67, 128-145
7. Heck AM, Yanovski JA & Calis KA (2000) Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy 20, 270-279
8. Pittler MH & Ernst E (2004) Dietary supplements for bodyweight reduction: A systematic review. Am J Clin Nutr 79, 529-536
9. Delaney B, Nicolosi RJ, Wilson TA, et al.(2003) Beta-glucan fractions from barley and oats are similarly antiatherogenic in hypercholesterolemic Syrian golden hamsters. J Nutr 133, 468-475
10. Babi'cek K, Cechová I, Simon RR, et al.(2007) Toxicological assessment of a particulate yeast (1,3/1,6)-beta-D-glucan in rats. Food Chem Toxicol 45, 1719-1730
11. McIntosh M, Stone BA & Stanisich VA (2005) Curdlan and other bacterial (1(3)-beta-D-glucans. Appl Microbiol Biotechnol 68, 163-173
12. Reyna-Villasmil N, Bermu'dez-Pirela V, Mengual-Moreno E, et al.(2007) Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia. Am J Ther 14, 203-212
13. AbuMweis SS, Jew S & Ames NP (2010) b-Glucan from barley and its lipid-lowering capacity: A meta-analysis of randomized, controlled trials. Eur J Clin Nutr 64, 1472-1480
14. Nicolosi R, Bell SJ, Bistrian BR, et al.(1999) Plasma lipid changes after supplementation with beta-glucan fiber from yeast. Am J Clin Nutr 70, 208-212
15. Marlett JA, Hosig KB, Vollendorf NW, et al.(1994) Mechanism of serum cholesterol reduction by oat bran. Hepatology 20, 1450-1457
16. Asp NG, Mattsson B & Onning G (1992) Variation in dietary fibre, beta-glucan, starch, protein, fat and hull content of oats grown in Sweden 1987-1989. Eur J Clin Nutr 46, 31-37
17. Wursch P & Pi-Sunyer FX (1997) The role of viscous soluble fiber in the metabolic control of diabetes. A review with special emphasis on cereals rich in beta-glucan. Diabetes Care 20, 1774-1780
18. de Groot A, Luyken R & Pikaar NA (1963) Cholesterollowering effect of rolled oats. Lancet ii, 303-304
19. Carr TP, Gallaher DD, Yang CH, et al.(1996) Increased intestinal contents viscosity reduces cholesterol absorption efficiency in hamsters fed hydroxypropyl methylcellulose. J Nutr 126, 1463-1469
20. Xiu A, Kong Y, Zhou M, et al.(2010) The chemical and digestive properties of a soluble glucan from Agrobacterium sp. ZX09. Carbohydr Polym 82, 623-628
21. Xiu A, Zhan Y, Zhou M, et al.(2011) Results of a 90-day safety assessment study in mice fed a glucan produced by Agrobacterium sp. ZX09. Food Chem Toxicol 49, 2377-2384
22. Xiu A, Zhou M, Zhu B, et al.(2011) Rheological properties of Salecan as a new source of thickening agent. Food Hydrocol 25, 1719-1725
23. Bae IY, Lee S, Kim SM, et al.(2009) Effect of partially hydrolyzed oat b-glucan on the weight gain and lipid profile of mice. Food Hydrocol 23, 2016-2021
24. Folch J, Lees MS & Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509
25. Haug A & Høstmark AT (1987) Lipoprotein lipases, lipoproteins and tissue lipids in rats fed fish oil or coconut oil. J Nutr 117, 1011-1017
26. Pasquier B, Armand M, Guillon F, et al.(1996) Viscous soluble dietary fibers alter emulsification and lipolysis of triacylglycerols in duodenal medium in vitro. J Nutr Biochem 7, 293-302
27. Schmid F, Stone BA, McDougall BM, et al.(2001) Structure of epiglucan, a highly side-chain/branched (1 ! 3;1 ! 6)-betaglucan from the micro fungus Epicoccum nigrum Ehrenb. ex Schlecht. Carbohydr Res 331, 163-171
28. Šandula J, Kogan G, Kačuráková M, et al.(1999) Microbial (1 ! 3)-b-D-glucans, their preparation, physico-chemical characterization and immunomodulatory activity. Carbohydr Polym 38, 247-253
29. Lairon D (2007) Dietary fiber and control of body weight. Nutr Metab Cardiovasc Dis 17, 1-5
30. Burkitt DP (1971) Epidemiology of cancer of colon and rectum. Cancer 28, 3-13
31. Burkitt DP (1973) The role of refined carbohydrate in large bowel behaviour and disease. Plant Food Man 1, 5-9
32. Sanchez D, Muguerza B, Moulay L, et al.(2008) Highly methoxylated pectin improves insulin resistance and other cardiometabolic risk factors in Zucker fatty rats. J Agric Food Chem 56, 3574-3581
33. Pittler MH & Ernst E (2001) Guar gum for body weight reduction: Meta-analysis of randomized trials. Am J Med 110, 724-730
34. Pasquier B, Armand M, Castelain C, et al.(1996) Emulsification and lipolysis of triacylglycerols are altered by viscous soluble dietary fibres in acidic gastric medium in vitro. Biochem J 314, 269-275
35. Borel P, Armand M, Ythier P, et al.(1994) Hydrolysis of emulsions with different triglycerides and droplet sizes by gastric lipase in vitro. Effect on pancreatic lipase activity. J Nutr Biochem 5, 124-133
36. Armand M, Borel P, Ythier P, et al.(1992) Effects of droplet size, triacylglycerol composition, and calcium on the hydrolysis of complex emulsions by pancreatic lipase: An in vitro study. J Nutr Biochem 3, 333-341
37. Nozaki Y, Fujita K, Yoneda M, et al.(2009) Long-term combination therapy of ezetimibe and acarbose for nonalcoholic fatty liver disease. J Hepatol 51, 548-556
38. Madsen L, Guerre-Millo M, Flindt EN, et al.(2002) Tetradecylthioacetic acid prevents high fat diet induced adiposity and insulin resistance. J Lipid Res 43, 742-750
39. Choi JS, Kim H, Jung MH, et al.(2010) Consumption of barley beta-glucan ameliorates fatty liver and insulin resistance in mice fed a high-fat diet. Mol Nutr Food Res 54, 1004-1013
40. Yokoyama WH & Shao Q (2006) Soluble fibers prevent insulin resistance in hamsters fed high saturated fat diets. Cereal Foods World 51, 16-18
41. Kerckhoffs DA, Brouns F, Hornstra G, et al.(2002) Effects on the human serum lipoprotein profile of beta-glucan, soy protein and isoflavones, plant sterols and stanols, garlic and tocotrienols. J Nutr 132, 2494-2505
42. Kerckhoffs DA, Hornstra G & Mensink RP (2003 Cholesterol-lowering effect of beta-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when beta-glucan is incorporated into bread and cookies. Am J Clin Nutr 78, 221-227
43. Theuwissen E & Mensink RP (2007) Simultaneous intake of beta-glucan and plant stanol esters affects lipid metabolism in slightly hypercholesterolemic subjects. J Nutr 137, 583-588
44. Davy BM, Davy KP, Ho RC, et al.(2002) High-fiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middleaged and older men. Am J Clin Nutr 76, 351-358
45. Behall KM, Scholfield DJ & Hallfrisch J (2004) Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women. Am J Clin Nutr 80, 1185-1193
46. Colhoun HM, Betteridge DJ, Durrington PN, et al.(2004 Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebocontrolled trial. Lancet 364, 685-696
47. Anderson JW & Gustafson NJ (1988) Hypocholesterolemic effects of oat and bean products. Am J Clin Nutr 48, 749-753
48. Eastwood MA & Passmore R (1983) Dietary fibre. Lancet ii, 202-206
49. Maki KC, Davidson MH, Torri S, et al.(2000) Highmolecular-weight hydroxypropylmethylcellulose taken with or between meals is hypocholesterolemic in adult men. J Nutr 130, 1705-1710
50. Delaney B, Carlson T, Zheng GH, et al.(2003) Repeated dose oral toxicological evaluation of concentrated barley beta-glucan in CD-1 mice including a recovery phase. Food Chem Toxicol 41, 1089-1102
51. Story L, Anderson JW, Chen WJ, et al.(1985) Adherence to high-carbohydrate, high-fiber diets: Long-term studies of non-obese diabetic men. J Am Diet Assoc 85, 1105-1110.